Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2015	Dec. 31, 2014
Current Assets
Cash and cash equivalents (variable interest entities restricted - 2015: $259; 2014: $190)	$ 7,623	$ 5,654
Accounts and notes receivable:
Trade (net of allowance for doubtful receivables - 2015: $95; 2014: $110)	4,398	4,685
Other	3,769	4,687
Inventories	7,822	8,101
Deferred income tax assets - current	807	812
Other current assets	433	328
Total current assets	24,852	24,267
Investments
Investment in nonconsolidated affiliates	4,464	4,201
Other investments (investments carried at fair value - 2015: $1,936; 2014: $2,009)	2,272	2,439
Noncurrent receivables	736	620
Total investments	7,472	7,260
Property
Property	55,751	55,230
Less accumulated depreciation	36,893	37,179
Net property (variable interest entities restricted - 2015: $2,502; 2014: $2,726)	18,858	18,051
Other Assets
Goodwill	12,261	12,632
Other intangible assets (net of accumulated amortization - 2015: $3,742; 2014: $3,737)	3,743	3,768
Deferred income tax assets - noncurrent	2,004	2,135
Asbestos-related insurance receivables - noncurrent	51	62
Deferred charges and other assets	643	621
Total other assets	18,702	19,218
Total Assets	69,884	68,796
Current Liabilities
Notes payable	426	551
Long-term debt due within one year	1,850	394
Accounts payable:
Trade	3,893	4,481
Other	2,195	2,299
Income taxes payable	981	361
Deferred income tax liabilities - current	119	105
Dividends payable	565	563
Accrued and other current liabilities	3,176	2,839
Total current liabilities	13,205	11,593
Long-Term Debt (variable interest entities nonrecourse - 2015: $1,062; 2014: $1,229)	17,462	18,838
Other Noncurrent Liabilities
Deferred income tax liabilities - noncurrent	546	622
Pension and other postretirement benefits - noncurrent	9,515	10,459
Asbestos-related liabilities - noncurrent	399	438
Other noncurrent obligations	3,483	3,290
Total other noncurrent liabilities	13,943	14,809
Redeemable Noncontrolling Interest	108	202
Stockholders’ Equity
Preferred stock, series A	4,000	4,000
Common stock	3,107	3,107
Additional paid-in capital	4,900	4,846
Retained earnings	25,411	23,045
Accumulated other comprehensive loss	(8,585)	(8,017)
Unearned ESOP shares	(278)	(325)
Treasury stock at cost	(4,222)	(4,233)
The Dow Chemical Company’s stockholders’ equity	24,333	22,423
Non-redeemable noncontrolling interests	833	931
Total equity	25,166	23,354
Total Liabilities and Equity	$ 69,884	$ 68,796